$3.95
▲ $0.06 (+1.5%)
NEUP
Neuphoria Therapeutics Inc. Common Stock
Health Care
Investor Score
46D+
Moderate rating
Based on 6 of 7 weighted categories, computed from real, live financial data only.
41
Technical
30
Fundamental
66
Growth
50
Fair Value
56
News
—
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.